Simvastatin treatment for 28 days
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Akron Children's Hospital
Overview
Simvastatin treatment for 28 days is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Simvastatin treatment for 28 days clinical trials
Explore related
Medical disclaimer. This page summarizes research about Simvastatin treatment for 28 days for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.